These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Lemieux I; Alméras N; Mauriège P; Blanchet C; Dewailly E; Bergeron J; Després JP Can J Cardiol; 2002 Jul; 18(7):725-32. PubMed ID: 12167959 [TBL] [Abstract][Full Text] [Related]
3. [Risk factors associated with obesity: a metabolic perspective]. Després JP; Pascot A; Lemieux I Ann Endocrinol (Paris); 2000 Dec; 61 Suppl 6():31-38. PubMed ID: 11148334 [TBL] [Abstract][Full Text] [Related]
4. Is visceral obesity the cause of the metabolic syndrome? Després JP Ann Med; 2006; 38(1):52-63. PubMed ID: 16448989 [TBL] [Abstract][Full Text] [Related]
5. Health consequences of visceral obesity. Després JP Ann Med; 2001 Nov; 33(8):534-41. PubMed ID: 11730160 [TBL] [Abstract][Full Text] [Related]
6. Contribution of CB1 blockade to the management of high-risk abdominal obesity. Després JP; Lemieux I; Alméras N Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S44-52. PubMed ID: 16570106 [TBL] [Abstract][Full Text] [Related]
10. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555 [TBL] [Abstract][Full Text] [Related]
11. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile. Blackburn P; Lemieux I; Alméras N; Bergeron J; Côté M; Tremblay A; Lamarche B; Després JP Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769 [TBL] [Abstract][Full Text] [Related]
12. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Fox CS; Massaro JM; Hoffmann U; Pou KM; Maurovich-Horvat P; Liu CY; Vasan RS; Murabito JM; Meigs JB; Cupples LA; D'Agostino RB; O'Donnell CJ Circulation; 2007 Jul; 116(1):39-48. PubMed ID: 17576866 [TBL] [Abstract][Full Text] [Related]
13. Clustering of metabolic abnormalities in adolescents with the hypertriglyceridemic waist phenotype. Esmaillzadeh A; Mirmiran P; Azizi F Am J Clin Nutr; 2006 Jan; 83(1):36-46; quiz 183-4. PubMed ID: 16400047 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease under the influence of excess visceral fat. Després JP Crit Pathw Cardiol; 2007 Jun; 6(2):51-9. PubMed ID: 17667865 [TBL] [Abstract][Full Text] [Related]
16. The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. Arsenault BJ; Lemieux I; Després JP; Wareham NJ; Kastelein JJ; Khaw KT; Boekholdt SM CMAJ; 2010 Sep; 182(13):1427-32. PubMed ID: 20643837 [TBL] [Abstract][Full Text] [Related]
17. The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol. Gazi IF; Filippatos TD; Tsimihodimos V; Saougos VG; Liberopoulos EN; Mikhailidis DP; Tselepis AD; Elisaf M Lipids; 2006 Jul; 41(7):647-54. PubMed ID: 17069348 [TBL] [Abstract][Full Text] [Related]
18. Visceral adiposity and risk of coronary heart disease in relatively lean Chinese adults. Zhang X; Shu XO; Li H; Yang G; Xiang YB; Cai Q; Ji BT; Gao YT; Zheng W Int J Cardiol; 2013 Oct; 168(3):2141-5. PubMed ID: 23453877 [TBL] [Abstract][Full Text] [Related]
19. Obesity, Visceral Fat, and Hypertension-Related Complications. Haberka M; Stolarz-Skrzypek K; Biedroń M; Szóstak-Janiak K; Partyka M; Olszanecka-Glinianowicz M; Gąsior Z Metab Syndr Relat Disord; 2018 Dec; 16(10):521-529. PubMed ID: 30183499 [No Abstract] [Full Text] [Related]